Inappropriate use of antibiotics in hospitals, community along with severity of illness, length of ICU stay, exposure to invasive devices, increased contact with health care personnel may contribute to the emergence of resistance. 5 It is gained by spontaneous mutation and acquiring new resistant gene from other species by horizontal transfer. 3, 4 Resistance pattern vary from region to region depending on antibiotic use. 6 An antibiotic policy avoids unnecessary use of broad spectrum antibiotics thereby decrease the development of resistant strains. 7 It is urgent to start proper empirical antibiotic before obtaining the microbial results, but emergence of multiple expanded spectrum of beta lactamase (ESBL) producing microbes and Multidrug resistant (MDR) pathogens, MRSA other categories of gram negative bacilli (GNB), make it difficult. Infectious disease society of America addressed three categories of gram negative bacilli, namely ESBL producing E. Coli and Klebsiella, MDR Pseudomonas and carbapenem resistant acinetobactor spp. are priority pathogen causing severity in ICU. 8 Data on prevalent strains along with the susceptibility pattern can help in revising antibiotic policy and guiding clinicians for more proper antibiotic selection. 9 Therefore, the present study was designed to know the bacterial profile and determine the antimicrobial resistance pattern among the microbes isolated from LRT of patients admitted to the ICU of Square Hospitals Ltd a 300 bedded tertiary care hospital in Dhaka city. 
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Conclusion: Farmenter and nonfermenters are the both common etiological agents of lower respiratory tract infections in this intensive care unit. There is high rate of resistance to commonly used cephalosporin and β-lactam-β-lactamase inhibitors and quinolone group of drugs. Acinetobacter baumannii, Pseudomonas aeruginisa and Klebsiella showed most sensitivity to Colistin and actually no resistance was found.
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Materials and Methods:
The present retrospective study was conducted in the microbiology department of Square Hospitals Ltd. in Dhaka during 2010-2011. Sputum, tracheal aspirates and broncho alveolar lavage (BAL) collected aseptically from 210 patients of most of them required mechanical ventilation. All samples were plated right after the collection and were further processed as per standard protocol. 10 Single or mixed growth isolated from all the eligible consecutive samples were identified by observing the colony characteristics on the blood agar, Mac-Conkey agar plate and biochemical reactions using standard microbiological methods. 10 Susceptibility testing was done by disc diffusion method. The following antibiotics (Hi-Media Disc in mcg) were tested: Amikacin, ciprofloxacin, moxifloxacin, aztreonem, colistin, tetracycline, cotrimoxazole, ceftazidime , ceftizoxime, meropenem, amoxycillin / clavulanic acid, imipenem piperacillin / tazobactum. Zone diameter was measured and interpreted as per the Clinical and Laboratory Standards Institute (CLSI) guidelines.
Results:
Out of 210 specimens, 150 (71%) were culture positive whereas, 60 (29%) specimens showed no growth. From the 150 culture positive specimens, 216 isolates were recovered. Out of 216 isolates, 60% were with single isolate, 35% were with two isolates 5% were with more than two isolates. The third most pathogen in ICU P. aeruginosa (30-66%) to different common drugs and it is 61% resistant to ceftazidime, 45 to 50% to aminoglycoside, 40% to carbapenem, 30% to pipercillin tazobactum, 31% to cefepime, 39% to aztreonam. 10 So empirical treatment of suspected pseudomonas is better with pipercillin tazobactum or aminoglycoside.
K. pneumoniae (15-65%) is resistant to common antibiotics 52% resistant to ciprofloxacin, 15 to 30 % to aminoglycoside & 13 to 16% to carbapenem which is still low in our study ICU and suggested to with judicious use of aminoglycosides & carbapemems. We frequently use eftazidim , amikacin meropenem and piperacillin-tazobactum for pseudomonas infection. In our study we found 61% pseudomonas is resistant to ceftazidim, 45% to Amikacin, 55% to gentamycin and 40% to meropenem. The most sensitive antibiotic to pseudomonas is colistin followed by piperacillin -tazobactum and cefepime.
For MRSA, once a colony is established in an individual, it is almost impossible to eradicate, but can be suppressed for a short time which reduces the risk of the individual and hospital. 9 Healthcare personnel should undergo screening and suppression therapy for MRSA routinely. 9 MRSA & E. Coli are most sensitive to vancomycine & Linazolid and no resistance was found in our study. The second option to treat these organisms are aminoglycoside & co trimoxazole.
Candida species both albicans & non albicans was the 5 th frequent isolated organism found in our study & mostly immunocompromised patient with DM, poor nutritional status, use of high dose steroids & broad spectrum antibiotics.
12 they lack ideal treatment option. A vaccine is being on pipeline which would protect life threatening fungal infection. 13 In 2006-2007 a study in ICU of BIRDEM showed major organisms were pseudomonas (29.1%), Acinetobacter 27.5%, candida (12.8%), E coli (10.3%), klebsialla (9.7% In some US Hospitals pathogens like Acenetobactor Baumanni and Enterococcus faecalis are virtually untreatable because of acquisition of multiple determinant of resistance to antimicrobial agents. 13 Vancomycin resistant Staph. Aureus (VRSA) is also becoming a big challenge to ICU management in in some countries. Further studies are required to evaluate the use of Carbapenem and Colistin for ICU patients because of least number of reserved antibiotics remaining. So, judicious use of older and newer antimicrobial agents is essential to prevent the emergence of multidrug resistant bacteria in the ICU.
Conclusion:
Highly resistant Acinetobacter infection can be controlled by strictly cleaning fomites, instruments and sometime temporary closure of the unit. Skin disinfection of both patients and staff with chlorohexidine or polymixin is necessary. Biofilm producing pseudomonas survive in fomites and foems causes microabscess in alveolar wall and relapses with necrosis and needs strict preventive measures. Coliforms have more than 500 classes of ESBL enzymes, inappropriate antibiotic use and frequent skin contamination of both patients and staff with feaces of the patient can spread the infection. Compulsory hand washing of staff and visitors and rigorous cleaning of environment can help in preventive measures. Plasmid Profile Analysis (PPA) can help in identifying the source of infection. 15 
